• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定变构 P2X 受体拮抗剂 [C]SMW139 作为小胶质细胞激活的 PET 示踪剂。

Identification of the allosteric P2X receptor antagonist [C]SMW139 as a PET tracer of microglial activation.

机构信息

Department of Radiology & Nuclear Medicine, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.

School of Chemistry, University of Sydney, Sydney, Australia.

出版信息

Sci Rep. 2018 Apr 26;8(1):6580. doi: 10.1038/s41598-018-24814-0.

DOI:10.1038/s41598-018-24814-0
PMID:29700413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5920098/
Abstract

The P2X receptor plays a significant role in microglial activation, and as a potential drug target, the P2X receptor is also an interesting target in positron emission tomography. The current study aimed at the development and evaluation of a potent tracer targeting the P2X receptor, to which end four adamantanyl benzamide analogues with high affinity for the human P2X receptor were labelled with carbon-11. All four analogues could be obtained in excellent radiochemical yield and high radiochemical purity and molar activity, and all analogues entered the rat brain. [C]SMW139 showed the highest metabolic stability in rat plasma, and showed high binding to the hP2X receptor in vivo in a hP2X receptor overexpressing rat model. Although no significant difference in binding of [C]SMW139 was observed between post mortem brain tissue of Alzheimer's disease patients and that of healthy controls in in vitro autoradiography experiments, [C]SMW139 could be a promising tracer for P2X receptor imaging using positron emission tomography, due to high receptor binding in vivo in the hP2X receptor overexpressing rat model. However, further investigation of both P2X receptor expression and binding of [C]SMW139 in other neurological diseases involving microglial activation is warranted.

摘要

P2X 受体在小胶质细胞激活中发挥重要作用,作为潜在的药物靶点,P2X 受体也是正电子发射断层扫描中的一个有趣靶点。本研究旨在开发和评估一种针对 P2X 受体的有效示踪剂,为此,我们用碳-11 标记了 4 种对人 P2X 受体具有高亲和力的金刚烷苯甲酰胺类似物。所有 4 种类似物都可以以优异的放射化学产率和高放射化学纯度和摩尔活性获得,并且所有类似物都进入了大鼠脑内。[C]SMW139 在大鼠血浆中的代谢稳定性最高,在 hP2X 受体过表达大鼠模型中体内显示出对 hP2X 受体的高结合。尽管在体外放射自显影实验中,阿尔茨海默病患者死后脑组织与健康对照者之间 [C]SMW139 的结合没有明显差异,但由于在 hP2X 受体过表达大鼠模型中体内具有高受体结合,[C]SMW139 仍可能成为使用正电子发射断层扫描进行 P2X 受体成像的有前途的示踪剂。然而,需要进一步研究 [C]SMW139 在涉及小胶质细胞激活的其他神经疾病中的 P2X 受体表达和结合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/aad99e8149ee/41598_2018_24814_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/c75bc0d79402/41598_2018_24814_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/1812662cfd72/41598_2018_24814_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/c9a2ac61b524/41598_2018_24814_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/442a04f83d32/41598_2018_24814_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/e09f9f4eab8d/41598_2018_24814_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/007dcbf5dec9/41598_2018_24814_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/ec1c07ecbaeb/41598_2018_24814_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/7bb2ca8a4e90/41598_2018_24814_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/feca941c23a1/41598_2018_24814_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/aad99e8149ee/41598_2018_24814_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/c75bc0d79402/41598_2018_24814_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/1812662cfd72/41598_2018_24814_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/c9a2ac61b524/41598_2018_24814_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/442a04f83d32/41598_2018_24814_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/e09f9f4eab8d/41598_2018_24814_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/007dcbf5dec9/41598_2018_24814_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/ec1c07ecbaeb/41598_2018_24814_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/7bb2ca8a4e90/41598_2018_24814_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/feca941c23a1/41598_2018_24814_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9882/5920098/aad99e8149ee/41598_2018_24814_Fig10_HTML.jpg

相似文献

1
Identification of the allosteric P2X receptor antagonist [C]SMW139 as a PET tracer of microglial activation.鉴定变构 P2X 受体拮抗剂 [C]SMW139 作为小胶质细胞激活的 PET 示踪剂。
Sci Rep. 2018 Apr 26;8(1):6580. doi: 10.1038/s41598-018-24814-0.
2
PET imaging of P2XR in the experimental autoimmune encephalomyelitis model of multiple sclerosis using [C]SMW139.使用 [C]SMW139 对多发性硬化症实验性自身免疫性脑脊髓炎模型中的 P2XR 进行 PET 成像。
J Neuroinflammation. 2020 Oct 14;17(1):300. doi: 10.1186/s12974-020-01962-7.
3
Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [C]SMW139 and [F]F-DPA.使用[C]SMW139和[F]F-DPA通过P2X7受体和TSPO的PET成像评估β-淀粉样蛋白沉积小鼠模型中的神经胶质反应性。
EJNMMI Res. 2024 Mar 6;14(1):25. doi: 10.1186/s13550-024-01085-7.
4
Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates.一种P2X7受体选择性放射性示踪剂的临床前评估:在人P2X7受体局部过表达的大鼠模型和非人灵长类动物中的PET研究
J Nucl Med. 2016 Sep;57(9):1436-41. doi: 10.2967/jnumed.115.169995. Epub 2016 May 19.
5
The P2X receptor tracer [C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study.P2X受体示踪剂[C]SMW139作为多发性硬化症神经炎症的体内标志物:一项人体首次研究。
Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):379-389. doi: 10.1007/s00259-019-04550-x. Epub 2019 Nov 8.
6
Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [¹¹C]A-740003 as a novel tracer of neuroinflammation.P2X7受体拮抗剂[¹¹C]A - 740003作为神经炎症新型示踪剂的合成及初步临床前评价
J Labelled Comp Radiopharm. 2014 Jun 30;57(8):509-16. doi: 10.1002/jlcr.3206. Epub 2014 Jul 3.
7
Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of F-JNJ-64413739, a PET Radioligand for P2X7 Receptors.用于 P2X7 受体的 PET 放射性配体 F-JNJ-64413739 的临床前评估和非人类灵长类动物受体占有率研究。
J Nucl Med. 2019 Aug;60(8):1154-1159. doi: 10.2967/jnumed.118.212696. Epub 2019 Feb 7.
8
Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia.JNJ-55308942 的神经精神药理学:在神经炎症和快感缺失的动物模型中评估针对 P2X7 离子通道的临床候选药物。
Neuropsychopharmacology. 2018 Dec;43(13):2586-2596. doi: 10.1038/s41386-018-0141-6. Epub 2018 Jul 9.
9
New approach in radiometabolite analysis of positron emission tomography (PET) radioligands; lead-shielded microextraction by packed sorbent as a tool for in vivo radiometabolite analysis of [C]SMW139 in rat plasma.正电子发射断层扫描(PET)放射性配体的代谢产物分析新方法;采用填充吸附剂的铅屏蔽微萃取作为体内分析 [C]SMW139 放射性代谢产物的工具。
Talanta. 2020 Feb 1;208:120449. doi: 10.1016/j.talanta.2019.120449. Epub 2019 Oct 5.
10
PET Imaging of the P2X7 Ion Channel with a Novel Tracer [F]JNJ-64413739 in a Rat Model of Neuroinflammation.新型示踪剂[F]JNJ-64413739 对神经炎症大鼠模型中 P2X7 离子通道的 PET 成像研究。
Mol Imaging Biol. 2019 Oct;21(5):871-878. doi: 10.1007/s11307-018-01313-2.

引用本文的文献

1
Resynchronization of microglial activity in the brain is associated with restoration of motor function in Parkinson's disease.大脑中微胶质细胞活动的重新同步与帕金森病运动功能的恢复有关。
Commun Biol. 2025 Aug 9;8(1):1188. doi: 10.1038/s42003-025-08602-x.
2
Radioligands Targeting the Purinergic P2X Receptors.靶向嘌呤能P2X受体的放射性配体
Cells. 2025 Jun 27;14(13):984. doi: 10.3390/cells14130984.
3
Advance and Prospect of Positron Emission Tomography in Alzheimer's disease research.正电子发射断层扫描在阿尔茨海默病研究中的进展与展望

本文引用的文献

1
Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis.嘌呤能受体 P2Y12R 和 P2X7R:多发性硬化症中小胶质细胞表型 PET 成像的潜在靶点。
J Neuroinflammation. 2017 Dec 22;14(1):259. doi: 10.1186/s12974-017-1034-z.
2
Pharmacological Evaluation of Novel Bioisosteres of an Adamantanyl Benzamide P2X Receptor Antagonist.新型金刚烷苯甲酰胺 P2X 受体拮抗剂的药效学评价。
ACS Chem Neurosci. 2017 Nov 15;8(11):2374-2380. doi: 10.1021/acschemneuro.7b00272. Epub 2017 Aug 25.
3
Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel F-labelled PET tracer targeting P2X7.
Mol Psychiatry. 2025 Jun 21. doi: 10.1038/s41380-025-03081-2.
4
P2X -receptor binding in new-onset and secondary progressive MS - a [C]SMW139 PET study.新发和继发进展型多发性硬化症中P2X受体结合——一项[C]SMW139正电子发射断层扫描研究
EJNMMI Res. 2024 Dec 5;14(1):123. doi: 10.1186/s13550-024-01186-3.
5
Roles in Innate Immunity.先天免疫中的角色。
Adv Neurobiol. 2024;37:263-286. doi: 10.1007/978-3-031-55529-9_15.
6
Increased Cerebral Level of P2X7R in a Tauopathy Mouse Model by PET Using [F]GSK1482160.正电子发射断层扫描(PET)用[F]GSK1482160 显示载脂蛋白 E 敲除tau 蛋白病小鼠模型大脑中 P2X7R 水平增加
ACS Chem Neurosci. 2024 Jun 5;15(11):2112-2120. doi: 10.1021/acschemneuro.4c00067. Epub 2024 May 22.
7
Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [C]SMW139 and [F]F-DPA.使用[C]SMW139和[F]F-DPA通过P2X7受体和TSPO的PET成像评估β-淀粉样蛋白沉积小鼠模型中的神经胶质反应性。
EJNMMI Res. 2024 Mar 6;14(1):25. doi: 10.1186/s13550-024-01085-7.
8
Non-invasive imaging of brain and retinal microglia in neurodegenerative diseases.神经退行性疾病中脑和视网膜小胶质细胞的无创成像
Front Cell Neurosci. 2024 Jan 29;18:1355557. doi: 10.3389/fncel.2024.1355557. eCollection 2024.
9
Spotlight on P2X7 Receptor PET Imaging: A Bright Target or a Failing Star?聚焦 P2X7 受体 PET 成像:是明日之星还是黯淡无光?
Int J Mol Sci. 2023 Jan 10;24(2):1374. doi: 10.3390/ijms24021374.
10
PET Imaging of Fructose Metabolism in a Rodent Model of Neuroinflammation with 6-[F]fluoro-6-deoxy-D-fructose.用 6-[F]氟-6-脱氧-D-果糖对神经炎症的啮齿动物模型进行果糖代谢的 PET 成像。
Molecules. 2022 Dec 3;27(23):8529. doi: 10.3390/molecules27238529.
一种新型靶向P2X7的F标记PET示踪剂在脂多糖诱导的啮齿动物神经炎症模型中的设计、合成及评估
EJNMMI Res. 2017 Dec;7(1):31. doi: 10.1186/s13550-017-0275-2. Epub 2017 Apr 4.
4
Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response.一种用于神经炎症反应的P2X7受体特异性放射性配体[11C]GSK1482160的药理学特性。
Nucl Med Commun. 2017 May;38(5):372-382. doi: 10.1097/MNM.0000000000000660.
5
Characterization of C-GSK1482160 for Targeting the P2X7 Receptor as a Biomarker for Neuroinflammation.C-GSK1482160靶向P2X7受体作为神经炎症生物标志物的特性研究
J Nucl Med. 2017 Mar;58(3):458-465. doi: 10.2967/jnumed.116.181354. Epub 2016 Oct 20.
6
The microglial ATP-gated ion channel P2X7 as a CNS drug target.作为中枢神经系统药物靶点的小胶质细胞ATP门控离子通道P2X7
Glia. 2016 Oct;64(10):1772-87. doi: 10.1002/glia.23001. Epub 2016 May 24.
7
Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates.一种P2X7受体选择性放射性示踪剂的临床前评估:在人P2X7受体局部过表达的大鼠模型和非人灵长类动物中的PET研究
J Nucl Med. 2016 Sep;57(9):1436-41. doi: 10.2967/jnumed.115.169995. Epub 2016 May 19.
8
P2X ion channel receptors and inflammation.P2X离子通道受体与炎症
Purinergic Signal. 2016 Mar;12(1):59-67. doi: 10.1007/s11302-015-9493-0. Epub 2016 Jan 6.
9
Purinergic mechanisms in neuroinflammation: An update from molecules to behavior.神经炎症中的嘌呤能机制:从分子到行为的最新进展
Neuropharmacology. 2016 May;104:94-104. doi: 10.1016/j.neuropharm.2015.09.019. Epub 2015 Sep 16.
10
Synthesis of [(11)C]GSK1482160 as a new PET agent for targeting P2X(7) receptor.新型正电子发射断层显像(PET)靶向P2X(7)受体显像剂[(11)C]GSK1482160的合成
Bioorg Med Chem Lett. 2015 May 1;25(9):1965-70. doi: 10.1016/j.bmcl.2015.03.021. Epub 2015 Mar 14.